All filters
Abstracts
Sex-specific analyses in oral abstracts from CROI 2019
W. Short Reviews in Antiviral Therapy & Infectious Diseases 1, 2020
Presented at:
International Workshop on HIV & Women 2020
Abstracts
Outcomes following prenatal exposure to Dolutegravir: the Dolomite-EPPICC Study
C. Thorne Reviews in Antiviral Therapy & Infectious Diseases 1, 2020
Presented at:
International Workshop on HIV & Women 2020
Abstracts
Vitamin D status in pregnant women living with HIV in Denmark and association with birth outcomes - A nationwide cohort study
E. Moseholm Reviews in Antiviral Therapy & Infectious Diseases 1, 2020
Presented at:
International Workshop on HIV & Women 2020
Abstracts
Impact of Dolutegravir based ART among Indian women
S. Poongulali Reviews in Antiviral Therapy & Infectious Diseases 1, 2020
Presented at:
International Workshop on HIV & Women 2020
Abstracts
Adolescent girls and young women: should they be formally recognized as a key population for HIV?
M. Nash Reviews in Antiviral Therapy & Infectious Diseases 1, 2020
Presented at:
International Workshop on HIV & Women 2020
Abstracts
Maternal and cord plasma bioactive eicosanoid profiles differ in pregnant women living with HIV compared to HIV-negative pregnant women
L. Serghides Reviews in Antiviral Therapy & Infectious Diseases 1, 2020
Presented at:
International Workshop on HIV & Women 2020
Abstracts
Women on anti-retroviral therapy (ART) are less likely to achieve HIV RNA <50 copies/ml compared to men – Real World Data from the National Swedish InfCareHIV Cohort
Å. Mellgren Reviews in Antiviral Therapy & Infectious Diseases 1, 2020
Presented at:
International Workshop on HIV & Women 2020
Abstracts
Not recommended, but done: Breastfeeding with HIV in Germany
L. Haberl Reviews in Antiviral Therapy & Infectious Diseases 1, 2020
Presented at:
International Workshop on HIV & Women 2020
Abstracts
Determinants of PrEP initiation in women at high risk for HIV
R. Scott Reviews in Antiviral Therapy & Infectious Diseases 1, 2020
Presented at:
International Workshop on HIV & Women 2020
Abstracts
Validating incident pregnancies among women using contraceptives and antiretrovirals
R. Patel  Reviews in Antiviral Therapy & Infectious Diseases 1, 2020
Presented at:
International Workshop on HIV & Women 2020
Abstracts
Post-Exposure Prophylaxis in victims of sexual violence. Experience at the Condesa Specialized Clinic (CSC)
T. Cabrera López Reviews in Antiviral Therapy & Infectious Diseases 1, 2020
Presented at:
International Workshop on HIV & Women 2020
Abstracts
Examining differences in syndemic factors by gender and sexual orientation among women, straight men, and gay, bisexual, and other men who have sex with men living with HIV in British Columbia, Canada
K. Closson Reviews in Antiviral Therapy & Infectious Diseases 1, 2020
Presented at:
International Workshop on HIV & Women 2020
Abstracts
CD4:CD8 ratio normalization among treatment naive women
A. Zhabokritsky Reviews in Antiviral Therapy & Infectious Diseases 1, 2020
Presented at:
International Workshop on HIV & Women 2020
Abstracts
Attitudes towards health, sexual intimacy, and child-bearing among women living with HIV in 24 countries
C. Okoli Reviews in Antiviral Therapy & Infectious Diseases 1, 2020
Presented at:
International Workshop on HIV & Women 2020
Abstracts
Differences by gender and sexual orientation in treatment satisfaction and aspirations among persons living with HIV
C. Okoli Reviews in Antiviral Therapy & Infectious Diseases 1, 2020
Presented at:
International Workshop on HIV & Women 2020
Abstracts
Gender, equality, and empowered decision making in HIV care
C. Okoli Reviews in Antiviral Therapy & Infectious Diseases 1, 2020
Presented at:
International Workshop on HIV & Women 2020
Abstracts
Impact of microbial exposures on HPV immune titers and infection among HPV-vaccinated women living with HIV
E. McClymont Reviews in Antiviral Therapy & Infectious Diseases 1, 2020
Presented at:
International Workshop on HIV & Women 2020
Abstracts
Women race, age and regional US & non-US subgroup analysis of dolutegravir (DTG) and non-integrase inhibitor treatment (non-INSTI) regimens in naïve randomized clinical trials at Week 48.
R. Quercia Reviews in Antiviral Therapy & Infectious Diseases 1, 2020
Presented at:
International Workshop on HIV & Women 2020
Abstracts
ATLAS and FLAIR: efficacy, pharmacokinetics and reasons for satisfaction in women with cabotegravir & rilpivirine long acting regimen at week 48
R. Quercia Reviews in Antiviral Therapy & Infectious Diseases 1, 2020
Presented at:
International Workshop on HIV & Women 2020
Abstracts
Dolutegravir-containing ART does not reduce etonogestrel implant concentrations
R. Patel Reviews in Antiviral Therapy & Infectious Diseases 1, 2020
Presented at:
International Workshop on HIV & Women 2020
Abstracts
Cabotegravir: Assessment of reproductive and developmental toxicity in animal studies1
M. Ziejewski Reviews in Antiviral Therapy & Infectious Diseases 1, 2020
Presented at:
International Workshop on HIV & Women 2020
Abstracts
Achieving the third 95: Keeping adolescents living with HIV virally suppressed in rural Nigeria in test and treat era using Continuous Quality Improvement Model of Peer Counseling & Support Group
S. Usman Reviews in Antiviral Therapy & Infectious Diseases 1, 2020
Presented at:
International Workshop on HIV & Women 2020
Abstracts
Cabotegravir pharmacokinetic tail in pregnancy and neonatal outcomes
Reviews in Antiviral Therapy & Infectious Diseases 1, 2020
Presented at:
International Workshop on HIV & Women 2020